Benzinga | May 4, 2021 04:27PM EDT

PTC Therapeutics Q1 EPS $(1.83) Misses $(1.51) Estimate, Sales $117.94M Beat $98.80M Estimate

PTC Therapeutics (NASDAQ:PTCT) reported quarterly losses of $(1.83) per share which missed the analyst consensus estimate of $(1.51) by 21.19 percent. This is a 1.1 percent decrease over losses of $(1.81) per share from the same period last year. The company reported quarterly sales of $117.94 million which beat the analyst consensus estimate of $98.80 million by 19.37 percent. This is a 72.79 percent increase over sales of $68.26 million the same period last year.